CVE-2026-61315
Vulnerability in the Oracle EDI Gateway product of Oracle E-Business Suite (component: EDI). ...
Vulnerability in the Oracle EDI Gateway product of Oracle E-Business Suite (component: EDI). Supported versions that are affected are 12.2.3-12.2.15. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle EDI Gateway. Successful attacks of this vulnerability can result in unauthorized read access to a subset of Oracle EDI Gateway accessible data. CVSS 3.1 Base Score 4.3 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N).
Attack profile
How easy it is to exploit
- Attack vector
- Network
- Complexity
- Low
- Privileges needed
- Low
- User interaction
- None
What an attacker can affect
- Confidentiality
- Low
- Integrity
- None
- Availability
- None
Exploit likelihood
What each source reports
CVE List Score used
4.3
Vulnerability in the Oracle EDI Gateway product of Oracle E-Business Suite (component: EDI). Supported versions that are affected are 12.2.3-12.2.15. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle EDI Gateway. Successful attacks of this vulnerability can result in unauthorized read access to a subset of Oracle EDI Gateway accessible data. CVSS 3.1 Base Score 4.3 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N).
- Record
CVE-2026-61315- CVSS 3.1
- 4.3 Medium
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N - Weakness
- CWE-200
- Updated
- 2026-11-02
EUVDEUVD-2026-47479
4.3
Vulnerability in the Oracle EDI Gateway product of Oracle E-Business Suite (component: EDI). Supported versions that are affected are 12.2.3-12.2.15. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle EDI Gateway. Successful attacks of this vulnerability can result in unauthorized read access to a subset of Oracle EDI Gateway accessible data. CVSS 3.1 Base Score 4.3 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N).
- Record
EUVD-2026-47479- CVSS 3.1
- 4.3 Medium
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N - Updated
- 2026-11-02
GitHub AdvisoriesGHSA-mhrf-wc66-vv5r
4.3
Vulnerability in the Oracle EDI Gateway product of Oracle E-Business Suite (component: EDI). ...
Vulnerability in the Oracle EDI Gateway product of Oracle E-Business Suite (component: EDI). Supported versions that are affected are 12.2.3-12.2.15. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle EDI Gateway. Successful attacks of this vulnerability can result in unauthorized read access to a subset of Oracle EDI Gateway accessible data. CVSS 3.1 Base Score 4.3 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N).
- Record
GHSA-mhrf-wc66-vv5r- CVSS 3.1
- 4.3 Medium
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N - Weakness
- CWE-200
- Updated
- 2026-11-02
NVD
4.3
Vulnerability in the Oracle EDI Gateway product of Oracle E-Business Suite (component: EDI). Supported versions that are affected are 12.2.3-12.2.15. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle EDI Gateway. Successful attacks of this vulnerability can result in unauthorized read access to a subset of Oracle EDI Gateway accessible data. CVSS 3.1 Base Score 4.3 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N).
- Record
CVE-2026-61315- CVSS 3.1
- 4.3 Medium
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N - Weakness
- CWE-200
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| first indexed | CVE List, EUVD, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2026-61315 is a medium vulnerability (CVSS 4.3) in Oracle E-business Suite, published July 21, 2026. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.30%, the 23rd percentile. No source names a fixed version.